Current Report · Items 1.01, 2.03, 9.01 · 8-K
ProPhase Labs, Inc.
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 1.01. Entry into a Material Definitive Agreement. On July 31, 2026, ProPhase Labs, Inc. (the “Company”) entered into a Loan Agreement with J.J. Astor & Co. (the “Lender”) providing for a senior secured convertible loan in the original principal amount of $2,085,000 in exchange for funding of $1,500,000, before the deduction of agreed-upon fees, reserves and other amounts provided for in the Loan Agreement.…
Filed Aug 6, 2026Accepted Aug 6, 2026, 5:00 PM EDTCIK 868278Accession 0001493152-26-036383
Company context
We are a next-generation biotech, genomics and consumer products company. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds, and diagnostics.
Current securities
Historical securities (2)
Registered securities in this filing
PROPHASE LABS, INC. · 8-K · Filed 2026-08-06
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $0.0005
- Symbol
- PRPH
- Exchange
- Not supplied
- Classification
- COMMON
Filing context
Context: AsOf2026-07-31
Dimensions: Not supplied
Accession 000149315226036383 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 1.01, 2.03, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01. Entry into a Material Definitive Agreement.
On
July 31, 2026, ProPhase Labs, Inc. (the “Company”) entered into a Loan Agreement with J.J. Astor & Co. (the “Lender”)
providing for a senior secured convertible loan in the original principal amount of $2,085,000 in exchange for funding of $1,500,000,
before the deduction of agreed-upon fees, reserves and other amounts provided for in the Loan Agreement. The Company received net proceeds
at closing of $1,020,000 in accordance with the terms of the Loan Agreement. The loan is payable in weekly installments and matures in
accordance with the terms set forth in the Loan Agreement.
The
Loan Agreement contains customary representations and warranties, affirmative and negative covenants, and events of default.
The
foregoing description of the Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the Loan
Agreement, which is filed as Exhibit 10.1 to this Current Report and is incorporated herein by reference.
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The
information set forth under Item 1.01 of this Current Report is incorporated herein by reference.